Don't Believe Everything You Read in Medical Journals

Elsevier Health Sciences, the huge Philadelphia-based publisher of medical journals, is dealing with a little embarrassment right now, at the least.
Apparently, its Austrialian unit published content favorable to Merck, including its controversial Vioxx drug, without revealing that journals publishing those articles were in fact paid for by Merck. The practice, which Elsevier says stopped in 2005, came to light in a court case in Australia involving Vioxx. See AP article here and Elsevier's apology here. The story was first reported by The Australian newspaper; The Scientist reported last week on the full magnitude of the problem.


Daily Links 5/8/09: First Round Capital's "Office Hours" planned for Philly

Liberty Media Reports First Quarter Financial Results (PR Newswire via MSN Money)
QVC revenue down 10%.

E-commerce stocks rebound rapidly, up 36% for 2009 (Internet Retailer)

TicketLeap Goes Anywhere With Online DIY Box Office Solution (TechCrunch)

Calling all Philadelphia Entrepreneurs (Redeye VC)
First Round Capital's "Office Hours" coming to Philly on May 18.

Boomi Wins 2009 CODiE Award for Best On-Demand Platform (Marketwire)

Newtown’s Lockheed Martin secures $1 billion satellite deal (Bucks Local News)

Universal Display Corporation Announces First Quarter 2009 Financial Results (Business Wire)
Behold The Future! OLED Gadgets Arrive (Motley Fool)

Motorola Preps Phone-Enabled TV Remote
Vendor Targets Q4 For Rechargeable Voice Remote For IPTV Set-Tops
(Multichannel News)

An interview with Ralph Roberts, Part 2 (Comcast Voices)

MedQuist Reports First Quarter 2009 Results (PR Newswire via MSN Money)

Philly newspapers get 60-day stay from lawsuits (Associated Press via The Legal Intelligencer)



permalink